Norris Medicines Management
Management criteria checks 3/4
Norris Medicines' CEO is Vimal Shah, appointed in Apr 2015, has a tenure of 9.58 years. directly owns 23.6% of the company’s shares, worth ₹50.82M. The average tenure of the management team and the board of directors is 9.6 years and 0.6 years respectively.
Key information
Vimal Shah
Chief executive officer
₹600.0k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 9.6yrs |
CEO ownership | 23.6% |
Management average tenure | 9.6yrs |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -₹8m |
Jun 30 2024 | n/a | n/a | -₹9m |
Mar 31 2024 | ₹600k | n/a | -₹12m |
Dec 31 2023 | n/a | n/a | -₹19m |
Sep 30 2023 | n/a | n/a | -₹18m |
Jun 30 2023 | n/a | n/a | -₹19m |
Mar 31 2023 | ₹600k | n/a | -₹17m |
Dec 31 2022 | n/a | n/a | -₹34m |
Sep 30 2022 | n/a | n/a | -₹34m |
Jun 30 2022 | n/a | n/a | -₹36m |
Mar 31 2022 | ₹600k | n/a | -₹33m |
Dec 31 2021 | n/a | n/a | -₹42m |
Sep 30 2021 | n/a | n/a | -₹43m |
Jun 30 2021 | n/a | n/a | -₹48m |
Mar 31 2021 | ₹600k | n/a | -₹50m |
Dec 31 2020 | n/a | n/a | -₹23m |
Sep 30 2020 | n/a | n/a | -₹28m |
Jun 30 2020 | n/a | n/a | -₹26m |
Mar 31 2020 | ₹600k | ₹600k | -₹28m |
Dec 31 2019 | n/a | n/a | -₹14m |
Sep 30 2019 | n/a | n/a | -₹20m |
Jun 30 2019 | n/a | n/a | -₹14m |
Mar 31 2019 | ₹600k | ₹600k | -₹17m |
Dec 31 2018 | n/a | n/a | -₹25m |
Sep 30 2018 | n/a | n/a | -₹20m |
Jun 30 2018 | n/a | n/a | -₹24m |
Mar 31 2018 | ₹600k | ₹600k | -₹25m |
Compensation vs Market: Vimal's total compensation ($USD7.10K) is below average for companies of similar size in the Indian market ($USD42.67K).
Compensation vs Earnings: Vimal's compensation has been consistent with company performance over the past year.
CEO
Vimal Shah (48 yo)
9.6yrs
Tenure
₹600,000
Compensation
Mr. Vimal Dhirendra Shah has been Managing Director at Norris Medicines Ltd. since April 1, 2015. Mr. Shah was the Chairman of Norris Medicines Limited since April 01, 2017 and its Executive Director since...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD & Executive Director | 9.6yrs | ₹600.00k | 23.6% ₹ 50.8m | |
Chief Financial Officer | 9.7yrs | ₹627.00k | no data | |
General Manager of Operations | no data | no data | no data | |
Company Secretary & Compliance Officer | less than a year | no data | no data | |
General Manager of Marketing | no data | no data | no data |
9.6yrs
Average Tenure
57.5yo
Average Age
Experienced Management: 524414's management team is seasoned and experienced (9.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD & Executive Director | 12.8yrs | ₹600.00k | 23.6% ₹ 50.8m | |
Non-Executive Director | less than a year | no data | no data | |
Non-Executive Independent Director | less than a year | no data | no data |
0.6yrs
Average Tenure
51yo
Average Age
Experienced Board: 524414's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.